The FDA has only approved six weight loss drugs, including: Bupropion-naltrexone (Contrave) Liraglutide (Saxenda) Orlistat (Xenical, Alli) Phentermine-topiramate (Qsymia) Semaglutide (Wegovy) Setmelanotide (Imcivree) Currently, the choice of weight loss drugs remains very limited and is divided into two main categories: pancreatic lipase inhibitors and appetite suppressants that act on the central nervous system
GLP-1 receptor agonist sales growth rates are around 50% a year for diabetes treatment, but much higher for the new classes of obesity-optimised GLP-1 receptor agonists
GLP-1 (Glucagon-Like Peptide-1) and GIP (Gastric Inhibitory Polypeptide) are hormones naturally produced in your intestines that help regulate blood sugar, appetite, and energy balance
It defends muscle as hard as it suppresses appetite
Effective integration of PGx into clinical practice can make well-supported, accessible data a standard part of care
Dress in layers that can be easily removed as needed, and keep your environment cool with adequate ventilation or air conditioning
